Hayflick L
Clin Geriatr Med. 1985 Feb;1(1):15-27.
It is only within the past ten years that biogerontology has become attractive to a sufficient number of biologists so that the field can be regarded as a seriously studied discipline. Cytogerontology, or the study of aging at the cellular level, had its genesis about 20 years ago when the dogma that maintained that cultured normal cells could replicate forever was overturned. Normal human and animal cells have a finite capacity to replicate and function whether they are cultured in vitro or transplanted as grafts in vivo. This phenomenon has been interpreted to be aging at the cellular level. Only abnormal somatic cells are capable of immortality. In recent years it has been found that the number of population doublings of which cultured normal cells are capable is inversely proportional to donor age. There is also good evidence that the number of population doublings of cultured normal fibroblasts is directly proportional to the maximum lifespan of ten species that have been studied. Cultures prepared from patients with accelerated aging syndromes (progeria and Werner's syndrome) undergo far fewer doublings than do those of age-matched controls. The normal human fibroblast cell strain WI-38 was established in 1962 from fetal lung, and several hundred ampules of these cells were frozen in liquid nitrogen at that time. These ampules have been reconstituted periodically and shown to be capable of replication. This represents the longest period of time that a normal human cell has ever been frozen. Normal human fetal cell strains such as WI-38 have the capacity to double only about 50 times. If cultures are frozen at various population doublings, the number of doublings remaining after reconstitution is equal to 50 minus the number of doublings that occurred prior to freezing. The memory of the cells has been found to be accurate after 23 years of preservation in liquid nitrogen. Normal human cells incur many physiologic decrements that herald the approach of their failure to divide. Many of these functional decrements are identical to decrements found in humans as they age. Thus it is likely that these decrements are also the precursors of age changes in vivo. The finite replicative capacity of normal cells is never seen to occur in vivo because aging and death of the individual occurs well before the doubling limit is reached.
仅仅在过去十年间,生物老年学才吸引了足够多的生物学家,从而使该领域能够被视为一门得到认真研究的学科。细胞老年学,即细胞水平上的衰老研究,大约起源于20年前,当时认为培养的正常细胞可以永远复制的教条被推翻。无论是在体外培养还是作为移植物在体内移植,正常人类和动物细胞的复制和功能能力都是有限的。这种现象被解释为细胞水平上的衰老。只有异常体细胞能够永生。近年来发现,培养的正常细胞能够进行的群体倍增次数与供体年龄成反比。也有充分证据表明,培养的正常成纤维细胞的群体倍增次数与已研究的十个物种的最大寿命成正比。早衰综合征(早老症和沃纳综合征)患者的细胞培养物所经历的倍增次数比年龄匹配的对照组要少得多。正常人类成纤维细胞系WI - 38于1962年从胎儿肺中建立,当时几百安瓿这种细胞被液氮冷冻。这些安瓿已定期复苏并显示能够复制。这代表了正常人类细胞被冷冻的最长时间。正常人类胎儿细胞系如WI - 38只能倍增约50次。如果在不同的群体倍增次数时冷冻培养物,复苏后剩余的倍增次数等于50减去冷冻前发生的倍增次数。已发现细胞在液氮中保存23年后记忆仍然准确。正常人类细胞会出现许多生理衰退,预示着它们即将无法分裂。这些功能衰退中的许多与人类衰老时发现的衰退相同。因此,这些衰退很可能也是体内衰老变化的先兆。正常细胞有限的复制能力在体内从未出现过,因为个体在达到倍增极限之前就已经衰老和死亡了。